-

Riffyn Appoints Former Greenlots Executive, Vipul Doshi, as VP of Software Engineering

Vipul’s leadership in healthcare SaaS and IoT, in high growth companies, and in successfully deploying large scale cloud software will accelerate Riffyn’s next stage of growth as a pioneer of Intelligent Process Development (IPD).

OAKLAND, Calif.--(BUSINESS WIRE)--Riffyn, the leading provider of SaaS for Intelligent Process Development (IPD), today announced that Vipul Doshi, a software leader in healthcare SaaS and IoT solutions, has been appointed as Riffyn’s Vice President of Software Engineering to accelerate the next stage of the company’s growth in the IPD market.

Vipul brings more than 25 years of software industry experience with notable success in driving breadth of cloud-hosted SaaS applications. His work at Greenlots (a Shell subsidiary) has been recognized as instrumental to the successful deployment of cloud based software for the largest fast charging electric vehicle network in North America. He brings expertise in building and leading globally distributed software engineering teams including Greenlots, Blink Network, and IGT.

"Riffyn's process-centric approach to orchestrating scientific data feeds the increasing needs for better data governance and readiness for machine learning in R&D labs,” said Vipul. “It has already transformed top biopharma and industrial biotech companies who are developing life-changing products. I'm thrilled to join this talented team, and look forward to delivering exceptional user experiences to our customers through new product features and improvements."

“Vipul’s expertise and experience in building cloud SaaS solutions, from start-ups to the large enterprises and across industries, will be invaluable to elevating Riffyn’s IPD-enabling platform to meet the accelerating demand for Riffyn Nexus in bioprocess and biotech organizations,” said Riffyn CEO Tim Gardner.

About Riffyn

Riffyn enables scientific R&D teams to bring products to market faster. A pioneer of Process Development Intelligence, its patented cloud software Riffyn Nexus® shapes data from thousands of experiments into formats ready for machine learning so scientists can get to deep process analytics quicker. Riffyn customers can aggregate data across process operations and collaborating teams to gain predictive insights on how to develop and optimize their laboratory and manufacturing processes. To learn more about how Riffyn is enabling the worlds’ most advanced R&D organizations to double their discovery-to-development speed visit riffyn.com or follow us on LinkedIn.

Contacts

Stephanie Yeung
media@riffyn.com

Riffyn


Release Versions

Contacts

Stephanie Yeung
media@riffyn.com

More News From Riffyn

Riffyn Recognized as a Representative Vendor for Intelligent Process Development in 2021 Gartner® Market Guide for Lab Informatics

OAKLAND, Calif.--(BUSINESS WIRE)--Riffyn, the leading SaaS provider of scientific lab informatics today announced that it has been recognized as a Representative Vendor in the two categories — Intelligent Process Development and LIMS — in the 2021 Gartner Market Guide for Laboratory Informatics1 report. Per the report, “Organizations are under extreme pressure to expedite discovery and their lab operations are not keeping up.” It states that “single-purpose lab IT applications for recording and...

Riffyn Identified in 2021 Gartner® Hype Cycle™ for Life Science Manufacturing, Quality and Supply Chain Report Under Two Categories — Bioprocessing Informatics and Enterprise Laboratory Informatics

OAKLAND, Calif.--(BUSINESS WIRE)--Riffyn Identified in 2021 Gartner® Hype Cycle™ for Life Science Manufacturing, Quality and Supply Chain report under two categories....

Riffyn Launches Riffyn Nexus v4.2 to Strengthen Bioprocess Data Integrity With Automated Data Validation

OAKLAND, Calif.--(BUSINESS WIRE)--Riffyn's pioneering cloud-based process data system for Intelligent Process Development has been upgraded with more powerful capabilities. The new features in Riffyn Nexus v4.2 enable customers to validate data real-time at a large scale with the ability to trace the root cause of an anomaly. Data integrity in process development is critical to rapid, high-quality drug and biotech product development. Inadequate data can mislead decisions and cost tens of milli...
Back to Newsroom